Univariate analysis showed that gender (male), ECOG-PS ≥ 2, current or former smokers, tumor stage IV, non-adenocarcinoma histology, wild-type EGFR status, neutrophilia and NLR ≥ 3.7 were significantly associated with worse OS (Table 2). This evidence concerns the gene EGFR and adenocarcinoma.